683 Capital Management, LLC 13F holdings, Q1 2025
Holdings as of March 31, 2025 · filings on SEC EDGAR · latest filing →
683 Capital Management, LLC disclosed 119 US equity positions worth $985.8m in its Q1 2025 13F filing. The largest position was COF at 5.6% of the reported book, followed by GXO and INSM. Against the Q4 2024 filing, it opened 6 new positions, added to 20 and reduced 14 among the top 50 holdings.
What did 683 Capital Management, LLC own in Q1 2025? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q4 2024 |
|---|---|---|---|---|---|---|---|
| 1 | COF CAPITAL ONE FINL CORP | Financial Services | 5.6% | $55.2m | 308,000 | -4% | reduced |
| 2 | GXO GXO LOGISTICS INCORPORATED | Industrials | 3.8% | $37.1m | 950,000 | 46% | added |
| 3 | INSM INSMED INC | 3.7% | $36.4m | 15,428,000 | 0% | held | |
| 4 | CVNA CARVANA CO | Consumer Cyclical | 3.6% | $36.0m | 172,000 | -24% | reduced |
| 5 | WVE WAVE LIFE SCIENCES LTD | Healthcare | 3.2% | $31.7m | 3,925,000 | 4% | added |
| 6 | HGV HILTON GRAND VACATIONS INC | Consumer Cyclical | 2.9% | $28.7m | 766,000 | -19% | reduced |
| 7 | BBIO BRIDGEBIO PHARMA INC | 2.9% | $28.3m | 24,750,000 | 0% | held | |
| 8 | UNH UNITEDHEALTH GROUP INC | Healthcare | 2.8% | $27.2m | 52,000 | – | new |
| 9 | PM PHILIP MORRIS INTL INC | Consumer Defensive | 2.6% | $25.4m | 160,000 | 0% | held |
| 10 | PTGX PROTAGONIST THERAPEUTICS INC | Healthcare | 2.5% | $24.2m | 500,000 | 22% | added |
| 11 | ERO ERO COPPER CORP | Basic Materials | 2.2% | $21.8m | 1,800,480 | -27% | reduced |
| 12 | WDC WESTERN DIGITAL CORP | Technology | 2.1% | $20.2m | 500,000 | 14% | added |
| 13 | AB ALLIANCEBERNSTEIN HLDG L P | 2.0% | $20.1m | 525,825 | – | new | |
| 14 | BBIO BRIDGEBIO PHARMA INC | Healthcare | 2.0% | $19.9m | 575,000 | -9% | reduced |
| 15 | AMTM AMENTUM HOLDINGS INC | Industrials | 1.9% | $18.4m | 1,013,000 | 138% | added |
| 16 | CCOI COGENT COMMUNICATIONS HLDGS | Communication Services | 1.8% | $18.1m | 295,000 | -2% | reduced |
| 17 | MGTX MEIRAGTX HLDGS PLC | 1.8% | $17.5m | 2,575,000 | 7% | added | |
| 18 | HES HESS CORP | 1.7% | $17.1m | 107,295 | 0% | held | |
| 19 | QURE UNIQURE NV | 1.7% | $16.4m | 1,550,000 | 2% | added | |
| 20 | BIDU BAIDU INC | Communication Services | 1.7% | $16.3m | 177,500 | 4% | added |
| 21 | CNC CENTENE CORP DEL | Healthcare | 1.6% | $16.1m | 265,000 | – | new |
| 22 | INSE INSPIRED ENTMT INC | 1.4% | $13.4m | 1,563,552 | -8% | reduced | |
| 23 | LEN/B LENNAR CORP | 1.3% | $12.5m | 115,000 | 0% | held | |
| 24 | ELV ELEVANCE HEALTH INC | Healthcare | 1.2% | $11.7m | 27,000 | – | new |
| 25 | TGTX TG THERAPEUTICS INC | Healthcare | 1.2% | $11.6m | 295,000 | -58% | reduced |
| 26 | PDD PDD HOLDINGS INC | Consumer Cyclical | 1.1% | $11.2m | 95,000 | 0% | held |
| 27 | KNOP KNOT OFFSHORE PARTNERS LP | Energy | 1.1% | $11.2m | 1,610,000 | 0% | held |
| 28 | SRPT SAREPTA THERAPEUTICS INC | Healthcare | 1.1% | $10.5m | 165,000 | 62% | added |
| 29 | XHR XENIA HOTELS & RESORTS INC | Real Estate | 1.1% | $10.5m | 890,000 | -11% | reduced |
| 30 | 2662247D ITEOS THERAPEUTICS INC | 1.1% | $10.4m | 1,750,000 | 91% | added | |
| 31 | MREO MEREO BIOPHARMA GROUP PLC | Healthcare | 1.1% | $10.4m | 4,635,000 | 2% | added |
| 32 | ASML ASML HOLDING N V | Technology | 1.1% | $10.4m | 15,650 | 0% | held |
| 33 | HRMY HARMONY BIOSCIENCES HLDGS IN | Healthcare | 1.0% | $10.0m | 300,000 | 0% | held |
| 34 | MRP MILLROSE PPTYS INC | Real Estate | 1.0% | $9.4m | 355,000 | – | new |
| 35 | CZR CAESARS ENTERTAINMENT INC NE | Consumer Cyclical | 1.0% | $9.4m | 375,000 | 24% | added |
| 36 | ZVRA ZEVRA THERAPEUTICS INC | 0.9% | $9.2m | 1,225,834 | 0% | held | |
| 37 | CRESY CRESUD S A C I F Y A | 0.9% | $9.2m | 830,000 | -6% | reduced | |
| 38 | PHAT PHATHOM PHARMACEUTICALS INC | 0.9% | $9.1m | 1,445,000 | 41% | added | |
| 39 | HHH HOWARD HUGHES HOLDINGS INC | Real Estate | 0.9% | $8.9m | 120,000 | -11% | reduced |
| 40 | AMLX AMYLYX PHARMACEUTICALS INC | Healthcare | 0.9% | $8.5m | 2,411,400 | 25% | added |
| 41 | WAL WESTERN ALLIANCE BANCORP | Financial Services | 0.9% | $8.5m | 110,000 | 10% | added |
| 42 | IOVA IOVANCE BIOTHERAPEUTICS INC | Healthcare | 0.8% | $8.0m | 2,400,000 | 69% | added |
| 43 | SG7 SAGE THERAPEUTICS INC | 0.8% | $8.0m | 1,000,000 | 59% | added | |
| 44 | MDGL MADRIGAL PHARMACEUTICALS INC | Healthcare | 0.8% | $7.8m | 23,576 | 2258% | added |
| 45 | ARIS ARIS MNG CORP | 0.8% | $7.5m | 1,625,000 | -10% | reduced | |
| 46 | VKTX VIKING THERAPEUTICS INC | Healthcare | 0.7% | $7.4m | 305,000 | 9% | added |
| 47 | APLSUSD APELLIS PHARMACEUTICALS INC | 0.7% | $7.3m | 333,000 | -7% | reduced | |
| 48 | MICROSTRATEGY INC | 0.7% | $7.1m | 5,000,000 | – | new | |
| 49 | GOSSAMER BIO INC | 0.7% | $7.0m | 13,145,000 | 8% | added | |
| 50 | GOSS GOSSAMER BIO INC | Healthcare | 0.7% | $6.7m | 6,100,000 | -13% | reduced |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.